Panel of experts – biotechnology

Print Friendly, PDF & Email

Panel of experts – biotechnology

Panel of experts assessing candidates for the position of Principal Investigator in the field of biotechnology

JANUSZ BUJNICKI, PhD, MSc, Prof.Tit.
B. in 1975, a professor of biological sciences (he obtained the title of professor in 2009) and head of a research group at the International Institute of Molecular and Cell Biology in Warsaw and at the Adam Mickiewicz University in Poznań. He conducts research combining bioinformatics, structural biology and synthetic biology. He developed, among others, methods of computer modeling of spatial structures of proteins and RNA. He designed and created proteins with new properties. He discovered and characterized new enzymes involved in RNA metabolism. Author of widely cited publications, winner of numerous grants, scholarships and awards for scientific achievements, including: Starting Grant ERC, Proof of Concept ERC, André Mischke Young Academy of Europe Prize for Science and Policy, Awards of the National Science Center (Poland), Awards of the Minister of Science and Higher Education (Poland), Awards of the Prime Minister (Poland). Winner of the national poll “Poles with verve” in the Science category (2013). Awarded with the Knight’s Cross of the Order of Polonia Restituta. Member of: Academia Europaea, EMBO, correspondent member of the Polish Academy of Sciences (PAN) and earlier of the Polish Young Academy of PAN. Member of the Group of Chief Scientific Advisors of the European Commission (2015-2020), representative of Poland in the European Science Advisors Forum, chairman of the University Council of the University of Warsaw (2019-2020).

 


PRZEMYSŁAW JUSZCZYŃSKI, MD, PhD, MSc, Prof. of the Institute of Hematology and Transfusion Medicine in Warsaw
Scientific Director of the Institute of Hematology and Transfusion Medicine in Warsaw, in which he also obtained a post-doctoral degree (habilitation) and was appointed associate professor, and in which he has been working as a professor since 2017. He graduated from the medical faculty of the Medical University of Lodz, where he then began doctoral studies and obtained a doctoral degree. During his doctoral studies, he received a START scholarship of the Foundation for Polish Science and completed training at the Department of Clinical Haematology and the Haematological Malignancy Diagnostic Service of Leeds General Infirmary in Leeds, Great Britain. After his doctorate, he received an ICRETT International Union Against Cancer scholarship (Geneva, Switzerland) and a KOLUMB scholarship from the Foundation for Polish Science and left the country for a postdoctoral fellowship to the Dana Farber Cancer Institute at the Harvard Medical School in Boston, Massachusetts. He completed numerous bioinformatics courses at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology in Cambridge, Massachusetts. After receiving the Leukemia & Lymphoma Society of America grant, he joined the junior staff of Harvard Medical School as a Medical Instructor. He devotes his research to the pathogenesis and targeted therapy of lymphatic cancer. He supervised various grants, including ones of the Polish National Science Center, Foundation for Polish Science, National Center for Research and Development, LLS. He supervised many doctoral students. Winner of various awards, including the J.K. Parnas Polish Biochemical Society Award, the Minister of Science Award for scientific achievements, the Koprowski Polish Society of Oncology Award.

 


MACIEJ DROŻDŻ, PhD
Maciej Drożdż, PhD has spent almost 15 years working in the venture capital and biotech industry. He served as a Principal of Venture Investments for Johnson and Johnson Development Corporation (JJDC) in London at the Johnson and Johnson Innovation Centre and as a CEO of Antagonis Biotherapeutics, an immuno-oncology company in Graz, Austria. Previously he was investment manager at Entrepreneurs Fund LLP, investment director at MCI Bioventures and an analyst at Atlas Venture. Maciek has served on a number of boards of private and public companies listed on stock exchanges across several countries. He received his Master’s Degree in molecular biology from the Adam Mickiewicz University in Poznań, Poland, followed by a doctorate at the University of Heidelberg in Germany. He has also worked as a postdoc at the Friedrich Miescher Institute in Basel, Switzerland. He holds an MBA degree from the Saïd Business School in Oxford. He lectured a course in “Innovation in Biotechnology” at Adam Mickiewicz University in Poznań.

Print Friendly, PDF & Email
plusfontminusfontreloadfont